Polyceutix

Copenhagen, United States

Polyceutix transforms cancer treatment by unleashing the full power of the immune system.

$540K raised

Feb 2024

Convertible Note

Top Investors

30,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has Polyceutix raised?

Polyceutix has raised $540K in total funding. The most recent round was Convertible Note. The last funding was announced in February 2024.

Who are Polyceutix's investors?

Polyceutix's investors include BioInnovation Institute.

Where is Polyceutix headquartered?

Polyceutix is headquartered in Copenhagen, United States.

What does Polyceutix do?

Polyceutix transforms cancer treatment by unleashing the full power of the immune system.

What stage is Polyceutix at?

Polyceutix is at the Convertible Note stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated February 29, 2024.

MLA

"Polyceutix — Funding & Investors." VCBacked, February 29, 2024, https://www.vcbacked.co/company/polyceutix. Accessed July 2, 2026.

APA

VCBacked. (2024). Polyceutix — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/polyceutix

Wikipedia (cite web)

{{cite web |title=Polyceutix — Funding & Investors |url=https://www.vcbacked.co/company/polyceutix |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated February 29, 2024.